FDA Adverse Event Malfunction Summary report: N

CARTO® 3 SYSTEM

MDR report key: 3023763 · Received March 27, 2013

Report

Report Number
3008203003-2013-00040
Event Type
Malfunction
Date Received
March 27, 2013
Date of Event
March 14, 2013
Report Date
March 14, 2013
Manufacturer
BIOSENSE WEBSTER, LTD (HAIFA, ISRAEL)
Product Code
DQK
PMA / PMN Number
K090017
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AU
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

REFER TO EVALUATION SUMMARY. (B)(4). IT WAS REPORTED THAT DURING AN AFIB PROCEDURE, ERRORS 932 AND 319 APPEARED AND THE CASE WAS RESCHEDULED BECAUSE OF THE PRODUCT ISSUE. THE PROCEDURE WAS BEING PERFORMED IN THE LEFT ATRIUM AND A TRANSSEPTAL PUNCTURE WAS PERFORMED PRIOR TO THE CASE CANCELLATION. THE PHYSICIAN DID NOT CONSIDER CANCELLING THE PROCEDURE CAUSED A POTENTIAL RISK TO THIS PATIENT. BIOSENSE FIELD SERVICE ENGINEERS REPORTED THAT THE ISSUE WAS NOT REPRODUCED DURING TROUBLESHOOTING AND THE CUSTOMER CONFIRMED THAT THE ISSUE COULD NOT BE REPRODUCED DURING NEXT TWO PROCEDURES. THE SYSTEM IS FULLY OPERATIONAL. SINCE THIS WAS A REPORTABLE EVENT, AN ADDITIONAL ORIGINAL EXTERNAL MANUFACTURER (OEM) ACTION (DHR REVIEW OR INVESTIGATION) WAS PERFORMED. NO ANOMALIES WERE NOTED IN MANUFACTURING OR SERVICE.

Additional Manufacturer Narrative · 1

(B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT DURING AN AFIB PROCEDURE, ERRORS 932 AND 319 APPEARED AND THE CASE WAS RESCHEDULED BECAUSE OF THE PRODUCT ISSUE. THE PROCEDURE WAS BEING PERFORMED IN THE LEFT ATRIUM AND A TRANSSEPTAL PUNCTURE WAS PERFORMED PRIOR TO THE CASE CANCELLATION. THE PHYSICIAN DID NOT CONSIDER CANCELING THE PROCEDURE CAUSED A POTENTIAL RISK TO THIS PATIENT. THE PATIENT DID NOT REQUIRE EXTENDED HOSPITALIZATION BECAUSE OF THE PROCEDURE CANCELLATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
125968 CARTO® 3 SYSTEM COMPUTER, DIAGNOSTIC, PROGRAMMABLE DQK BIOSENSE WEBSTER, LTD (HAIFA, ISRAEL) M-4800-01

Patients

Seq Age Sex Outcome Treatment
1